Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Interest of EMDR (Eye Movement Desensitization and Reprocessing) Psychotherapy in the Management of Schizophrenic Disorders

NCT05164289 is registered in ClinicalTrials.gov with Hôpital NOVO as lead sponsor.

NCT NCT05164289
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05164289 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Interest of EMDR (Eye Movement Desensitization and Reprocessing) Psychotherapy in the Management of Schizophrenic Disorders
Lead sponsor
Hôpital NOVO
Phase
Observational
Overall status
Terminated
Start date
December 10, 2021
Completion date
April 27, 2022
Enrollment
6 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

schizophrenic disorders